Carlisle Companies Incorporated (CSL) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Carlisle Companies Incorporated  (NYSE: CSL)

Carlisle Companies Incorporated's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Carlisle Companies Incorporated in the third quarter 2026?
Carlisle Companies Incorporated achieved a return on average equity (ROE) of 44.18 % in its third quarter 2026, this is above CSL's average return on equity of 21.01%.
Carlisle Companies Incorporated shareholder's equity over the 12 months ending in its third quarter 2026 are valued at $1,626 million

While the company's net income was fading, Carlisle Companies Incorporated was able to improve its ROE compared to the second quarter 2026.

Within the Medical Equipment & Supplies industry 5 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 269, from total ROE ranking in the second quarter 2026 at 323.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Equity Change -27.79 % -23.74 % -23.69 % -27.11 % -
Y / Y Net Income Change -2.85 % -0.23 % -10.89 % -21.74 % -12.32 %
Net Income (TTM) in Millions 718 725 725 741 776
Return On Equity (TTM) 44.18 % 41.06 % 38.36 % 36.69 % 35.51 %
CSL's Total Ranking # 269 # 323 # 290 # 296 # 179
Equity (TTM) in Millions 1,438 1,617 1,653 1,795 1,992
Seq. Equity Change -11.06 % -2.18 % -7.92 % -9.86 % -6.07 %
Seq. Net Income Change -18.46 % 99.84 % 0.24 % -40.52 % -16.26 %

Back to CSL Management Effectiveness >> CSL's 5 Years Annual ROE >> Compare CSL ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 6
Sector # 42
Overall # 269

Return On Equity Statistics
High Average Low
48.58 %
21.01 %
9.31 %
(Mar 31 2025)   (Jun 30 2017)





CSL Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 1,795 2,463 2,829 3,024 2,630
Y / Y Equity Change -27.11 % -12.93 % -6.46 % 15.02 % 3.62 %
Net Income in Millions 741 1,312 766 924 422
Y / Y Net Income Change -43.54 % 71.34 % -17.14 % 119.11 % 31.74 %
Return On Equity 41.26 % 53.25 % 27.06 % 30.55 % 16.04 %

Back to CSL Management Effectiveness >> CSL's 5 Years Annual ROE >> Compare CSL ROE to its Competitors




Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 41.26 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CSL's' Return on Equity at Yahoo Finance
CSL's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CSL's Competitors
Subscribers only: Roe for Carlisle Companies Incorporated's Suppliers
Subscribers only: Return On Equity for CSL's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Alector Inc   112.21 %
Medpace Holdings Inc   99.76 %
3m Company  93.07 %
Exelixis Inc   85.83 %
Eli Lilly And Company  83.65 %
Rigel Pharmaceuticals Inc  73.94 %
Idexx Laboratories Inc  71.18 %
Tenet Healthcare Corp  57.13 %
Aurinia Pharmaceuticals Inc   51.92 %
Nurix Therapeutics Inc   49.34 %
Carlisle Companies Incorporated  44.18 %
Bristol myers Squibb Company  43.83 %
Zevra Therapeutics Inc   38.02 %
Dexcom Inc   36.56 %
Rallybio Corporation  36.35 %
Caredx Inc   34.08 %
Chemed Corporation  32.10 %
Illumina Inc   31.45 %
Transmedics Group Inc   28.74 %
Acadia Pharmaceuticals Inc   28.03 %
Pro dex Inc   26.91 %
Sotera Health Company  26.41 %
Pacs Group Inc   25.65 %
Standard Biotools Inc   25.58 %
Resmed Inc   25.50 %
Bioventus Inc   24.60 %
Encompass Health Corporation  24.08 %
Iradimed Corporation  23.90 %
Corcept Therapeutics Inc  22.88 %
Msa Safety Inc  21.79 %

Date modified: 2026-10-30T16:59:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.